Cite

HARVARD Citation

    Efros, M. et al. (2016). The efficacy, bioavailability and safety of a novel hydroalcoholic testosterone gel 2% in hypogonadal men: results from phase II open‐label studies. Andrologia. pp. 637-645. [Online]. 
  
Back to record